ITX 5061

DRUG3 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), University of Birmingham, Schiano, Thomas D., MD

Conditions

Evidence of Liver TransplantationHepatitis CHepatitis C Infection

Phase 1

Evaluating the Safety of ITX 5061 in Treatment-Naive Hepatitis C (HCV)-Infected Adults

CompletedNCT01165359

National Institute of Allergy and Infectious Diseases (NIAID)Hepatitis C

Start: 2010-09-30End: 2012-03-31Updated: 2021-11-01

Pilot Study of Hepatitis C Virus Entry Inhibitor (ITX 5061) in Liver Transplant Recipients

CompletedNCT01292824

University of BirminghamEvidence of Liver Transplantation, Hepatitis C

Start: 2011-02-28End: 2013-05-31Updated: 2015-12-03

Study of Hepatitis C Virus (HCV) Entry Inhibitor in Liver Transplant Recipients With HCV Infection

TerminatedNCT01560468

Schiano, Thomas D., MDHepatitis C Infection

Start: 2012-03-31End: 2018-04-30Target: 10Updated: 2018-04-18